LTTS Partners with NVIDIA to Develop AI-Powered Digital Twin Platform for Respiratory Diagnostics

LTTS and NVIDIA Forge Strategic Partnership

L&T Technology Services (LTTS) has announced a groundbreaking collaboration with NVIDIA to develop a next-generation AI-powered digital twin platform specifically designed for respiratory diagnostics and lung navigation 1

1

. This strategic partnership combines LTTS' expertise in MedTech with NVIDIA's advanced AI infrastructure to deliver precision diagnostics and enhance patient care worldwide.

The collaboration represents a significant advancement in medical imaging technology, leveraging LTTS' strengths in platform engineering, connected health, advanced imaging, and AI diagnostics, all running on NVIDIA's accelerated computing technology 2

2

. The platform aims to deliver scalable, low-latency solutions that improve diagnostic precision and expand access to advanced imaging tools for clinicians globally.

Advanced Technology Integration

The innovative platform integrates seamlessly with CT imaging systems and utilizes sophisticated deep learning models to generate comprehensive 3D digital twins of lung anatomy 1

1

. Built on NVIDIA MONAI for medical image segmentation and NVIDIA TensorRT for optimized AI inference, the system enables detailed visualization of airways, blood vessels, lobes, and lesions.

The platform's capabilities extend beyond static imaging, offering interactive simulation and path-planning support for bronchoscopy procedures 1

1

. LTTS' engineering capabilities in medical imaging and proprietary navigation systems allow static CT scans to be converted into dynamic, clinically meaningful digital representations that evolve with patient data, creating what the companies term "biological digital twins."

Clinical Applications and Impact

The digital twin platform supports comprehensive planning and navigation for various respiratory conditions, including lung cancer, chronic obstructive pulmonary disease (COPD), and infectious diseases 1

1

. By converting traditional scans into dynamic models that evolve with patient health data, the system enables clinicians to visualize anatomy interactively, plan procedures with greater precision, and navigate bronchoscopies more effectively 2

2

.

"AI is reshaping what's possible in diagnostics and medical technology," said Alind Saxena, executive director and president of mobility and tech at LTTS 1

1

. The collaboration combines LTTS' expertise in AI-driven diagnostics and predictive analytics with NVIDIA's powerful modeling and visualization platform to create an immersive, real-time planning tool for clinicians.

NVIDIA's Healthcare AI Expansion

This partnership represents part of NVIDIA's broader strategy to expand its footprint in healthcare AI, moving significantly beyond its traditional gaming and graphics processing unit origins 2

2

. The company is positioned to capitalize on soaring demand for automation and AI in hospitals, with analyst projections suggesting NVIDIA's healthcare business could generate approximately $1 billion in annual recurring revenue by fiscal 2026.

David Niewolny, director of business development for healthcare/medical at NVIDIA, emphasized that the partnership demonstrates the potential for accelerated computing in clinical workflows 1

1

. "LTTS is enabling transformative solutions that bring the vision of real-time AI and biological digital twins powered by NVIDIA to clinical practice," Niewolny stated.

Market Debut and Future Prospects

The revolutionary platform will make its public debut at the Radiological Society of North America (RSNA) 2025 conference, where it will be showcased to healthcare professionals and industry experts 1

1

. This high-profile presentation represents a significant milestone in bringing advanced AI diagnostics to mainstream clinical practice.